Q32 Bio earnings were -$59.8M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest QTTB earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$11.0M, down 22.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, QTTB reported annual earnings of -$47.7M, with -11.2% growth.
On QTTB's earnings call on Invalid Date, Q32 Bio (NASDAQ: QTTB) reported Q1 2025 earnings per share (EPS) of -$0.90, up 187.38% year over year. Total QTTB earnings for the quarter were -$11.03 million. In the same quarter last year, Q32 Bio's earnings per share (EPS) was $1.03.
As of the last Q32 Bio earnings report, Q32 Bio is currently losing money. Q32 Bio's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$59.79 million, a 30.34% increase year over year.
What was QTTB's earnings growth in the past year?
As of Q32 Bio's earnings date in Invalid Date, Q32 Bio's earnings has grown year over year. QTTB earnings in the past year totalled -$59.79 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.